Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors

Bugiardini, Raffaele; Pavasović, Saša; Yoon, Jinsung; van der Schaar, Mihaela; Sasko Kedev; Marija Vavlukis; Vasiljevic, Zorana; Bergami, Maria; Miličić, Davor; Manfrini, Olivia; Cenko, Edina; Badimon, Lina

doi:10.1016/j.eclinm.2020.100548

Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors

Journal

EClinicalMedicine

Date Issued

2020-09-20

Author(s)

Bugiardini, Raffaele

Pavasović, Saša

Yoon, Jinsung

van der Schaar, Mihaela

Vasiljevic, Zorana

Bergami, Maria

Miličić, Davor

Manfrini, Olivia

Cenko, Edina

Badimon, Lina

DOI

10.1016/j.eclinm.2020.100548

Abstract

Controversy exists as to whether low-dose aspirin use may give benefit in primary prevention of cardiovascular (CV) events. We hypothesized that the benefits of aspirin are underevaluated.

Subjects

Aspirin

Primary prevention

ST segment elevation ...

File(s)

Name

Aspirin for primary prevention of ST segment elevation myocardial.pdf

Size

1.43 MB

Format

Adobe PDF

Checksum

(MD5):ca619dbffad3682615ac5076045804a1